Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Nikolaj Christian Torp

University of Southern Denmark

Denmark

Research Interests

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (17)

Mads Israelsen

Rigshospitalet

DENMARK

View details

Aleksander Krag

University of Southern Denmark

DENMARK

View details

Tommi Suvitaival

Researcher (Asst. Prof.-level)

Steno Diabetes Center Copenhagen

DENMARK

View details

Cristina Legido-Quigley

Reader in Systems Medicine

King's College London

UNITED KINGDOM

View details

Maja Thiele

Odense University Hospital

DENMARK

View details

Rafael Bañares

Full Professor

Universidad Complutense de Madrid

SPAIN

View details

Mathias Jachs

Medical University of Vienna

AUSTRIA

View details

Wim Laleman

MD PhD

BELGIUM

View details

Ida Katharina Ziegler Spedtsberg

Syddansk Universitet

DENMARK

View details

Maximilian Joseph Brol

University Hospital Münster

GERMANY

View details

Roberta Gagliardi

University of Padua

ITALY

View details

Michael Trauner

Professor of Medicine and Chair of Gastroenterology and Hepatology

Medical University of Vienna

AUSTRIA

View details

Marisa Isabell Keller

Københavns Universitet

DENMARK

View details

Alastair O'Brien

Clinical Professor of Hepatology

Queen Mary University of London

UNITED KINGDOM

View details

Giacomo Zaccherini

Tenured Assistant Professor of Internal Medicine

University of Bologna

ITALY

View details

Bernhard Wernly

AUSTRIA

View details

Mary E. Rinella

Professor of Medicine

University of Chicago Pritzker School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nikolaj Christian Torp

Research Interests

Articles (20)

Limitations of MELD and MELD 3.0 for prognostication in patients with cirrhosis hospitalized with acute decompensation: an analysis of the ATTIRE trial

PNPLA3 and TM6SF2 exacerbate the impact of alcohol and metabolic dysfunction on liver fibrosis

Health-related quality of life, compliance and sustained adherence on a low-carbohydrate high-fat diet compared with a high-carbohydrate low-fat diet in people with type 2 diabetes

Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver Disease

Fibrosis activity vs. disease stage

Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event.

Editorial: Two Common Risks, One Greater Harm—Diabetes and Alcohol in Steatotic Liver Disease

Limited clinical utility of serum-based ELISA PEth compared with whole-blood LC-MS/MS PEth to quantify alcohol consumption

Paired Liver Biopsies vs Noninvasive Tests as Surrogate Endpoints for Clinical Trials in Metabolic and Alcohol-Related Liver Disease and Alcohol-Related Liver Disease

The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial

PD-L1 and the risk of bacterial infection in patients with chronic liver diseases. An international multicohort study.

Editorial: Implementing Risk Assessment Tools for MetALD in Clinical Practice—Authors' Reply

MetALD: Diagnosis and Prognosis With Non-Invasive Tests

Phosphatidylethanol in steatotic liver disease

Refining Prognosis in Cirrhosis Patients With Ascites

Targeted albumin infusions in hospitalized patients with cirrhosis receiving terlipressin: A post-hoc analysis of ATTIRE

Prevalence, severity and determinants of steatotic liver disease among individuals with metabolic and alcohol risk from the community

Steatotic Liver Disease Classification is Dynamic, Affecting Clinical Trial Eligibility and Subclass-Specific Treatments

Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease

Evolving Paradigms in Albumin Therapy For Decompensated Cirrhosis

Collaborators (17)

Mads Israelsen

Aleksander Krag

Tommi Suvitaival

Cristina Legido-Quigley

Maja Thiele

Rafael Bañares

Mathias Jachs

Wim Laleman

Ida Katharina Ziegler Spedtsberg

Maximilian Joseph Brol

Roberta Gagliardi

Michael Trauner

Marisa Isabell Keller

Alastair O'Brien

Giacomo Zaccherini

Bernhard Wernly

Mary E. Rinella

Make your next move.